accuracy of cytologic diagnosis of tumor type depends critically on the availability to the cytopathologist of reliable clinical, radiologic, and other information and not only on the morphologic features of cells in smears. As pointed out by KOSS, "The same diagnostic parameters when applied to different organs will not work and may, in fact, result in diagnostic disaster^."^ Since the diagnosis of a particular tumor type often has important therapeutic and prognostic consequences, additional differentiationspecific or tissue-specific markers are needed in fine-needle aspirates (FNA) to provide information that combined with analysis of morphologic features of tumor cells and available clinical data can lead to precise diagnosis of tumor type.
In recent years the diagnostic value of intermediate filaments-as a group of such markers-has been documented in histologic sections of a wide variety of human tissues and tumors. 
Materials and Methods
Alcohol-fixed FNA biopsy specimens of 403 malignant tumors were collected over a period of 2 years in two cytopathology laboratories. They belonged to two groups: group A where specific cytologic diagnosis of tumor type was provided (27 1 cases collected at random) and group B in which diagnosis of major tumor categories could not be made with confidence (1 32 cases). Altogether there were 133 primary, 185 metastatic, 14 recurrent tumors, and 7 1 non-Hodgkin's malignant lymphomas (ML). Nonpalpable tumors underwent aspiration under computer tomography or ultrasonography guidance.
The aspirates used in this study are listed in Tables 1  to 7 . From each aspirate, at least four cytologic smears were prepared on glass slides. Two smears were fixed within a few seconds in 100% ethanol precooled to 4°C. After 1 to 6 hours at 4"C, they were air dried and then stored at -20°C to -30°C for 1 to 30 days before staining. Occasionally smears stored for several months at -30°C or -70°C were used. The other two smears were fixed, again within a few seconds, in 100% ethanol for 30 minutes and subsequently stained with hematoxylin and eosin for light microscopic study.
Immunohistochemical Procedures
For immunofluorescence, the smears were further fixed in 100% acetone at -10°C for 2 minutes. After a wash with phosphiate-buffered saline (PBS), 10 p1 of the first antibody was added, usually as a hybridoma supernatant, and the smears were incubated for 45 minutes at 37°C in a humid chamber. Often, because of the restricted amount of material available, circles were made on the glass slide antd parallel incubations with different first antibodies were performed on different parts of the same glass slide. After washing well with PBS, 10 p1 of fluorescein-labeled goat anti-mouse IgG (Cappell Laboratories, Cochraneville, PA), diluted 1:40, was added, and the smears were incubated for a further 30 minutes at 37°C. After an additional wash with PBS, the smears were mounted in Mowiol4-88 (Hoechst, Frankfurt, FRG) and examined in the fluorescence microscope. Double-label fluorescence staining was performed when necessary to ,adequately interpret the results." Usually a mouse monoclonal keratin (K) antibody and a guinea pig vimentin (V) antibody were given simultaneously as first antibodies. After washing in PBS, the two second antibodies were given simultaneously. Appropriate filters were used to separate the fluorescein isothiocyanate (FITC) and rhodamine labels in the fluorescence microscope.
Monoclonal antibodies used in this study were as follows: (1) KL1 a broad-specificity keratin antibody" (Dianova, Hamburg, FRG); (2) lu-5, a broad-specificity keratin antibody2' (obtained from Dr. C. Staehli, Central Research Division, F. Hoffmann-La Roche and Co., Ltd., Basel, Switzerland); (311 CK-2, a keratin antibody specific for keratin 18, which is typical of simple and transitional epithelia"; (4) V-9, a monoclonal vimentin antibody"; (5) DE-B-5, a monoclonal desmin (D) antib~d?~; (6) NR-4, an antibody specific for the 68-kilodalton polypeptide of mammalian neurofilaments (NF).24 0 It should be noted that hybridoma supernatants have been used in the current studies, whereas many of the same antibodies that are commercially available are sold as ascites fluids. Therefore tests to establish appropriate working dilutions are necessary. Although most results in this report have used immunofluorescence methods satisfactory results can be obtained with immunoperoxidase or alkaline phosphatase detection methlods. Again, however, assays to find the appropriate working dilution of the first antibodies are necessary.
Results
This study is based on IF typing of tumor cells in FNA biopsy specimens of 403 malignant tumors for which adequate follow-up information was available and in which the tumors were also in large majority subsequently characterized by histologic analysis. The fine-needle aspirates were prepared over a period of 2 years in two cytologic laboratories and represent approximately 8% of the specimens examined by fineneedle aspiration in conventional cytologic study over this time period. Fifty-three carcinomas, 14 malignant lymphomas, 14 sarcomas (including one epithelioid sarcoma. and one synovial sarcoma), seven malignant melanomas, eight Wilms' tumors, one Triton tumor, and one carcinoid of the lung have been published previously in reference^.^.' 7 3 1 8 , 2 5 -2 7
Fine-needle aspirates were divided for this study in two groups. Group A contained 27 1 cases collected at random in which the cytologic (diagnosis of tumor type appeared unambiguous and where an unambiguous diagnosis of tumor type, e.g., carcinoma (Ca), sarcoma (Sa), malignant lymphoma (ML), or malignant melanoma (MM) based only on the conventioinal light microscopic appearance could be made. Intermediate filament typing of tumor cells provided further independent evidence for the tumor type thus confirming the cytologic diagnosis in 262 of 27 1 of these cases. This group served to further correlate results obtained by convention,al cytologic study and by IF typing (Tables 1 and 2 ). In nine cases the initial cytologic diagnosis was changed after IF typing (Table 3) .
Group B contained 1 32 cases and included the majority of the cases encountered in the 2-year period in which malignant cells were easily diagnosed cytologically but where the tumor type could not be revealed with certainty (2.6% of the total). Usually, however, on the basis of light microscopic analysis of morphologic features of the tumor cells and the available clinical data one or two suggestions as to the possible major tumor type were given. Intermediate filament typing of tumor cells of cases in group B confirmed, changed or refined the initial cytologic suggestion of tumor type and in most of these instances made the final diagnosis more specific and accurate (Tables 4-6). (Tables 1 and 2 ). They included 24 malignant lymphomas (20 V+K-; four V+, K not tested), ten malignant melanomas (Figs. 1A and 1B) (all V+, six K-with the rest not tested), one plasmacytoma, and two cases of histiocytosis X (V+K-), and one carcinoid in the lung (K+NF+V-).
Group
All 35 sarcomas were vimentin positive. The tumor cells in five synovial sarcomas and one epithelioid sarcoma coexpressed vimentin and keratin. Six leiomyosarcomas coexpressed vimentin and desmin.
Tumor cells of the 189 carcinomas listed in Table 2 expressed keratin as assayed with a broad specificity keratin antibody irrespective of whether they were of primary or metastatic origin. Most carcinomas listed in Table 2 are keratin positive, vimentin negative ( Figs. 2A-2C ). However vimentin was coexpressed in the tumor cells of all primary or metastatic thyroid and renal cell carcinomas in our series (Figs. 3A-3C ). Vimentin coexpression also was noted in single examples of primary and metastatic small cell lung carcinoma and of primary adrenocortical carcinoma as well as in two recurrent endometrial carcinomas. In addition vimentin coexpression was noted in five of eight ovarian carcinomas, two of 13 primary breast carcinomas, one of three metastatic carcinomas of the prostate, one metastatic squamous carcinoma of the larynx, and seven metastatic carcinomas where the primaries were unknown.
Cytologic diagnosis of tumor type changed: In nine of 271 cases in group A (3.3%), the original cytologic diagnosis was carcinoma (Table 3) . However, IF typing showed only vimentin and not keratin in tumor cells in these nine cases. In seven cases numerous, quite pleomorphic small anaplastic tumor cells with scanty or moderate amounts of cytoplasm were present dispersed in the smears. Some were arranged in small loosely cohesive groups. After IF typing and reconsideration of the cytologic data these cases were finally diagnosed as malignant lymphomas, two of which involved breast lesions and five lymph nodes (Figs. 4A-4D). Subsequent examination of biopsy specimens in histologic analysis revealed large cell malignant lymphomas in all seven cases.
Case 3 10 was initially diagnosed cytologically as metastatic carcinoma. Tumor cells had epithelial-type morphologic features and variable amounts of cytoplasm. They were found dispersed and arranged in clusters of (Table 4) . These cases included 14 sarcomas, all of which were vimentin positive. Desmin positivity of the tumor cells in four cases confirmed the cytologic suggestions of rhabdomyosarcoma and leiomyosarcoma. One tumor which contained a mixture of vimentin and desmin and neurofilament-positive tumor cells was diagnosed as Triton tumor.
The cytologic suggestion of carcinoma was confirmed in 13 cases, since all contained keratin-positive tumor cells. In addition, true coexpression of keratin and vimentin was found in two carcinomas of the kidney, two large cell type carcinomas of the thyroid, and one undifferentiated carcinoma of the lung. True coexpression of keratin and neurofilaments was found in three cases of Merkel cell carcinoma. The presence of vimentin in tumor cells and the absence of keratin helped to confirm the cytologic suggestion of malignant melanoma in nine cases, in which no melanin pigment was present in tumor cells and malignant lymphoma in eight cases. Tumor cells from two neuroblastomas were neurofilament positive and vimentin negative. Finally, IF typing of four malignant tumors in whiclh cytologic study suggested Wilm's tumor revealed tumor cells containing vimentin and/or keratin as well as in two cases an additional population of desminpositive cells. Thus the diagnosis of Wilms' tumor was confirmed by IF typing.
Cytologic suggestion of tumor type changed: There were nine difficult aspirates in this group. All except one were composed of small, anaplastic malignant tumor cells, which displayed no apparent signs of differentiation at the light microscopic level (Table 5) . Therefore, although they were easily diagnosed as malignant, the possible tumor type could not be decided with confidence. In three All cases were later confirmed histologically except for nine pancreatic carcinomas, one liver cell carcinoma, five AdCa, and nine Ca with unknown primary. In these castes histologic types could not be obtained; however, follow-up was consistent with the diagnosis of carcinoma. In each case the finding of keratin positivity is consistent with the diagnosis of carcinoma. Some carcinomas coexpress keratin and vimentin (see text).
instances malignant lyniphoma was suggested, but since the tumor cells were vimentin negative and keratin positive, the diagnosis of imalignant lymphoma had to be reevaluated. In two cases, in which antibodies against keratins and neurofilaments revealed distinct IF aggregates (IF bodies) usually in a perinuclear position, a final diagnosis of Merkel cell carcinoma was p r o~i d e d .~~,~~ A further case was diagnosed as anaplastic carcinoma.
In five cases, carcinoma, small cell anaplastic carcinoma, transitional carcinoma (lymphoepithelioma), and carcinoid were suggested from the cytologic examination. Figure 1E (X400).
Since tumor cells were only vimentin positive and keratin negative, four of them were finally diagnosed as malignant lymphomas and one as amelanotic malignant melanoma.
Ambiguity of cytologic diagnosis of tumor type resolved:
The distinction between carcinoma and malignant lymphoma could not be made cytologically in 29 cases (Table  6 ). When the results of IF typing were known, 22 cases were diagnosed as malignant lymphoma (V+K-), six as carcinomas (V-K+) and one as malignant melanoma (V+K-).
There were nine cases in which the question of carcinoma or sarcoma could not be answered unequivocally at the light microscopic level. After IF typing seven were diagnosed as sarcomas (V+K-), including one leiomyosarcoma (V+D+), and two as carcinomas: one Merkel cell carcinoma of the skin (K+NF+V-) and one metastatic carcinoma where the primary was unknown.
There were five cases in which the differential diagnostic question of carcinoma or malignant melanoma could not be definitely solved at the light microscopic level. In three malignant melanomas tumor cells were vimentin positive, keratin negative but contain no melanin pigment. The remaining two cases were diagnosed as carcinomas since they were keratin positive. One of them, a kidney tumor, showed true coexpression of vimentin in tumor cells indicating a renal cell carcinoma.
The presence of vimentin and the absence of keratin helped in making the diagnosis of plasmacytoma in one of two cases in which the distinction between carcinoma and plasmocytoma could not be made on the cytologic evidence alone. In the other case carcinoma was diagnosed (V-K+).
Malignant lymphoma (V+K-D-NF-) was finally diagnosed in three of four cases in which a differential diagnosis between malignant lymphoma and sarcoma, neuroblastoma or hepatoblastoma had to be made. Tumor cells in the remaining case coexpressed vimentin and desmin indicating leiomyosarcoma.
In two cases cytologic analysis was in favor of either Wilms' tumor or rhabdomyosarcoma. Wilms' tumor was diagnosed (K+V+ some D+ cells); in the other, nonmuscle sarcoma (V+K-D-NF-).
In one case Ewing's tumor was finally diagnosed (V+D-NF-) and not a neuroblastoma which was also taken into consideration in the cytologic diagnosis.
In seven cases only malignant cells were diagnosed in the smear with no further suggestion being made. Six of them were rnalignant small round cell tumors of childhood. Intermediate filament typing helped to diagnose three of them as Wilms' tumors, one as neuroblastoma, and two as sarcomas including one rhabdomyosarcoma (Table 7) . One metastatic amelanotic melanoma could not be unambiguously diagnosed, since the differential diagnosis included sarcoma and both tumors are vimentin positive. For the same reason one malignant lymphoma appearing as a soft tissue tumor could not be distinguished from primary soft tissue sarcoma. However, use of leukocyte common antigen, which was positive on the tumor cells, allowed a diagnosis of lymphoma. In two cases, one neuroblastoma and one adrenal cortical carcinoma, no IF were found in tumor cells. In one retroperitoneal undifferentiated sarcoma in a child the cytologic diagnosis; was malignant small round blue cell tumor and therefore several tumor types had to be taken into consideration including malignant lymphoma. Since the tumor cells were only vimentin positive, neu- roblastoma and embryonal rhabdomyosarcoma could be excluded, but a distinction between malignant lymphoma and nonmusde sarcoma could not be made.
The cytologic diagnosis of germ cell tumors could not be decisively aided by IF typing of tumor cells. The majority of tumor cells in five seminomas were vimentin positive. In three tumors different percentages of K+V-tumor cells were present (i.e., less than 1%, 2%-5%, 10%-20%). Additionally, in one case a few tumor cells coexpressing keratin and vimentin were found (1%). In contrast the majority of tumor cells in three embryonal carcinomas and one teratocarcinoma was keratin positive. In two embryonal carcinomas as well as in the teratocarcinoma there was an additional population of vimentin-positive cells.
Discussion
Our findings document that IF typing of tumor cells in FNA is instrumental in determining the tumor type when combined with the light microscopic findings and clinical data. As detailed above our results are based on more than 400 cases which included the following: (A) 27 1 FNA biopsy specimens collected at random in which the correct and specific cytologic diagnosis of tumor type was apparent from the clinical data and the light microscopic study alone; this group was used to evaluate the reliability of IF tumor typing in various tumor categories as well as to find possible pitfalls in interpretation of results or areas of difficulty; and (B) 132 aspirates which although clearly containing malignant cells had given rise to diagnostic difficulty concerning major tumor categories because of lack of morphologic features indicating differentiation (or cell origin), lack of meaningful clinical data, or both. In these cases differential diagnosis comprised Ca, Sa, MM, ML, seminoma, plasmacytoma, neuroblastoma, Ewing's or Wilm's tumor. Intermediate filament typing of tumor cells in these cases helped to modify the initial cytologic diagnosis.
Limitations LfAspiration Biopsy Cytologic Analysis in Diagnosis of Major Tumor Types
The morphologic diagnosis of tumor type in FNA is in by far the majority of cases accurate and straightforward if malignant cells in the smears show distinct light microscopic features of differentiation, and in addition the clinical setting is appropriate and the diagnosis is made by a However, the diagnosis of tumor type in FNA (often even if combined with clinical data) clearly has its limitations.''6 Particularly in cases in which malignant cells in smears do not display recognizable morphologic features of differentiation the correct diagnosis of the major tumor type can be very difficult. This is best attested by the existence of so-called "difficult aspirates" and is reflected in their diagnoses. Apart from the straightforward diagnosis of malignancy, the cytologic report of these cases usually contains carefully expressed suggestions as to the possible differential diagnosis of tumor type. Various semantic manouvers are used to indicate the different degrees of certainty with which such suggestions are made. The fact is that morphologic diagnosis of tumor type in such cases is based on subjective rather than on objective criteria (since the latter simply do not exist in the smear or are expressed in the way difficult to grasp even by an experienced eye). This is supported by poor interobserver reproducibility among several cytopathologists (irrespective of their experience) in the diagnosis of tumor type in difficult aspirates with no detectable features indicating differentiation of tumor cells' and also by poor intraobserver agreement as to malignant cell types.* Our results further confirm this point. In this study the FNA were made by the same cytopathologists who later evaluated morphologic features of cells in the smears. Thus the clinical information obtained by talking to the patient, doctor, radiologist, etc., was taken into account in arriving at the initial cytologic diagnosis. Under these relatively ideal conditions with the group A tumors a small Sa: sarcoma; Ca: carcinoma; MM: malignant melanoma; M L malignant lymphoma.
percentage may be misdiagnosed (in our study nine of 271 or 3.3% group A tumors, Table 3 ). In group B there were still at least 132 aspirates amounting to approximately 2.6% tumors examined over a 2-year period in which the tumor type could not be unequivocally diagnosed (Tables 4-6 ). On the other hand, as a result of such an approach there were just eight cases (Tables 6 and 7) among 132 difficult aspirates (7%) in which the cytologic diagnosis was limited to malignant cells with no further suggestion of tumor type. In the other 124 cases the one (69 cases) or two (55 cases) suggestions of the most probable tumor type were used to formulate the diagnostic question to be answered by IF typing of tumor cells.
Usefulness of Intermediate Filament Typing of Tumor Cells in Diagnosis of Tumor Type in Histopathologic and Cytopathologic Study
Intermediate filaments have been shown to be differentiation-specific markers, and the diagnostic value of IF typing by means of monoclonal antibodies specific for a single filament type has been recognized and documented in histologic sections of a wide variety of human tissues and tumors by immunofluorescence, immunoperoxidase, or immunoalkaline phosphatase techniques. Carcinomas have been shown to be positive for keratin. Melanomas, malignant lymphomas, and the majority of nonmuscle sarcomas contain only vimentin. Rhabdomyosarcomas and leiomyosarcomas are desmin positive; glial fibrillary acidic protein can be found in tumors of glial origin, The majority of neuroblastomas contain neurofilaments34-36 whereas Ewing's sarcomas express ~i m e n t i n .~~ Several recent studies have suggested that IF typing can also be applied to typing tumor cells in FNA, and that it can improve the diagnosis of tumor type and help to solve common dilemmas of aspiration cytologic study such as differentiation of carcinoma from malignant lymphoma, melanoma, or sarcoma.5.7.'5-'s,25.26, 48 The diagnostic significance of true coexpression and pseudocoexpression of IF in FNA have been outlined and sources of false coexpression identified." In the current study (1) all tumors finally diagnosed as carcinomas in both groups A and B were keratin positive, (2) all tumors finally diagnosed as sarcomas in both groups were vimentin positive, and (3) all ML and MM in both groups were vimentin positive and those tested for the presence of keratin, also keratin negative. merits. 10-14.30-37 Table 8 compares the initial diagnosis based on cytologic and clinical data with the final cytologic diagnosis in which results obtained from IF typing of the tumor cells were also included. Of particular interest are those cases where IF typing resulted in a change in the diagnosis of tumor type.
Influence of Intermediate Filament Typing of Tumor Cells on Diagnosis of Tumor Type in This Series
In group A, Table 3 slhows that in eight of nine instances in which IF typing of the fine-needle aspirate changed the diagnosis subsequent histologic study supported the change in diagnosis. In the last case (carotid body tumor) the change in diagnosis was supported by arteriography and appearance of the tumor during operation.
In group B-the difficult cases-the most frequent diagnostic dilemma was to distinguish between ML and small cell carcinoma (30% of cases causing diagnostic difficulty) and in vast majority these cases turned out to be ML. Although the numbers of such cases may vary in different laboratories (depending on the type of material which a particular laboratory receives) this very clearly remains the major diagnostic problem of aspiration cytologic study in diagnosing tumor type in small cell anaplastic tumors in adults. Among 18 cases in which cytologic diagnosis or suggestion of tumor type was changed by IF typing of tumor cells there were 11 lymphomas 514 CANCER February 1 1989 Vol. 63 originally diagnosed or suggested as carcinomas (Tables  3 and 5 ). Moreover, ML was finally diagnosed in 22 of 29 cases in which the cytologic diagnosis listed both o p tions. It seems that in aspiration cytologic study, as in histopathologic examinati~n?~ if uncertainty exists between carcinoma or ML the tumor is more likely to be ML.
Our results agree with reports in which vimentin is the only IF type present in ML (although not 100% of the tumor cells are vimentin p o~i t i v e ) .~~.~~,~' They can be contrasted to others in which vimentin was found only in a fraction of the lymphomas that were examined. 
").
In 6% of difficult aspirates, carcinoma could not be distinguished from sarcoma by LM. Intermediate filament typing made this distinction possible in all cases since all sarcomas were vimentin positive keratin negative whereas carcinomas were keratin positive. Although the majority of carcinomas do not show coexpression of vimentin some carcinomas do (Table 2 , 4, and 6). If true coexpression of keratin and vimentin is found in an otherwise correctly diagnosed metastatic carcinoma of unknown origin, the search for the primary can first be concentrated on those sites where coexpression of keratin and vimentin is characteristic of primary carcinomas. 8327, 39348 In this series all thyroid, renal, and endometrial carcinomas coexpressed keratin and vimentin in the majority of cells. However, as an increasing number of carcinomas from different sites are studied, coexpression of keratin and vimentin is being reported in a few cases from other sites, although by far the majority of tumors from these sites express only keratin.30.44 For example in our series coexpression was noted in some cells in three of 13 small cell lung carcinomas, in two of 13 breast carcinomas, and in single examples of adrenocortical, prostatic, and squamous laryngeal carcinoma.
Tumor cells of two sarcoma types, i.e., synovial and epithelioid sarcomas4042 (Table 1) as well as the so-called malignant rhabdoid tumor of soft tissue43 can also coexpress vimentin and keratin. Thus in principle these sarcomas have to be taken into account in differential diagnosis with those carcinomas which coexpress keratin and vimentin. However, (1) these sarcomas are rare, and (2) from practical point of view only carcinomas metastatic to soft tissues would have to be taken into consideration since aspiration biopsy of a metastatic synovial or epithelioid sarcoma without the cytopathologist being aware of the existence or prior removal of the primary tumor would be exceptional.
Clearly, finding coexpression of IF in tumor cells in the smears adds important information relevant to the differential diagnosis of the tumor type but it has also drawbacks especially if light microscopic and clinical information does not permit an unequivocal diagnosis between carcinoma or sarcoma.
Malignant melanoma was readily confirmed or distinguished from carcinoma since tumor cells were only vimentin positive (Tables 1-3) .31 Usually within the framework of clinical and morphologic information MM did not have to be distinguished from ML. This would be impossible by IF typing since both tumors are vimentin positive. However, in rare cases in which this distinction has to be made one may be able to use specific antimelanoma antibodies54 to confirm MM, and leukocyte common antigen (LCA) to exclude MM and confirm ML.55756 In one case (Table 6, 
Limitations of Intermediate Filament Typing in Diagnosis of Tumor Type in Fine-Needle Aspiration
Intermediate filament typing cannot answer all questions in the diagnosis of tumor type in FNA. The cases listed in Table 7 illustrate some situations where difficulties can be expected. They can be divided as follows.
1. As already mentioned, tumors with the same IF content cannot be separated from one another. Thus MM cannot be separated from ML since both tumors are only vimentin positive. The same is true for sarcomas and ML or MM (Table 7) unless the former is a desmin-positive muscle sarcoma. In these instances clearly other markers have to be used, and immunochemistry with markers such as LCA, different lymphocyte-specific antigens, and other surface markers may help to solve these problem^.^^-^' 2. One can encounter malignant tumor cells entirely negative for IF. 59 We have two such cases: one adrenocortical carcinoma and one neuroblastoma ( 
Cytopathologist
Intermediate filament typing of tumor cells confirmed the correct cytologic diagnosis of tumor type in 26 1 cases in group A. One should not underestimate the value of confirming the cytologic diagnosis of tumor type since this confirmation is based on independent objective evidence and therefore it strengthens the certainty of cytologic diagnosis. Routine use of IF typing of tumor cells for confirmation of establisheld cytologic diagnosis in difficult cases can discover a few aspirates where the diagnosis will have to be changed (Table 3) , can help to distinguish primary tumor from an unexpected metastasis in a patient with removed and forgotten primary or to distinguish a metastasis from a second primary.66 Intermediate filament typing of tumor cells can reveal true coexpression of keratin and vimentin in otherwise correctly diagnosed metastatic carcinoma of unknown origin which narrows the search for the primary to those carcinomas known to coexpress these IF. As detailed for the group B tumors in Tables 4 through 6, IF typing is of particular value in cases where a differential diagnosis between major tumor types has to be made, and is in doubt.
Well-performed aspiration biopsy yields at least four but usually more slides. The alcohol fixation routinely used in cytologic study ensures good preservation of IF in tumor cells.
In our routine diagnostic laboratories several smears are left in alcohol until a decision is reached whether IF typing is necessary. If difficulties in tumor typing by light microscopic study are encountered the result of IF typing can be known within 2 hours. This vital information comes when the cytopathologist's interest in solving the diagnostic problem is at its peak. Thus there is an opportunity to learn, since morphologic features of tumor cells can be referred to unequivocally diagnosed tumor types. This is not to say that cytopathologists cannot learn by comparing morphologic features of tumor cells in difficult cases with the histologic sections from the same cases. But (1) such slides arrive usually weeks (rarely days) after the original cytologic diagnosis had been made; (2) to secure histologic slides of a particular case and compare them with smears, which are already in the files, requires time and energy not everybody can afford for every difficult case; (3) many cytologic laboratories do not have close ties with pathology units; and (4) many patients seek advice in different cities or countries so they disappear from the follow-up. In short, IF typing of tumor cells in aspirates provides the cytopathologist with the opportunity of continuing education based on the most difficult and therefore the most interesting and most informative cases. 
Summary
In summary, certainly FNA biopsy is a procedure whose time has come.33439 However, as pointed out in a recent report which stirred heated debate, "The current enthusiasm for needle aspiration has swept many into an uncritical application of the technique and an unrealistic effort to subclassify tumors without the aid of histology."6 This study shows that IF typing of tumor cells in needle aspirates adds objective differentiation specific and therefore histogenetically relevant information to the descriptive tumor typing currently used in aspiration cytologic study. It therefore makes efforts to diagnose major tumor types more realistic and certainly more accurate. When combined with morphologic study of tumor cells and clinical information it is an excellent method to refine the cytologic diagnosis of major tumor categories and therefore to prevent error. These findings suggest that diagnostic cytopathologic laboratories should routinely use IF typing of tumor cells in difficult aspirates where the diagnosis of tumor type is in doubt. This would benefit both the patient and the cytopathologist.
